SHANGHAI, China I August 1, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its ...

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in wet AMD, the leading cause of vision loss in people over ...

STUTTGART, Germany I August 02, 2025 I La Merie Publishing released its newest product entitled: B7-H3-Targeted Immunotherapy: a Competitor Analysis.